You are here

  • Home
  • Archive
  • Volume 11, Issue 1
  • Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies

 

Online download statistics by month:

Online download statistics by month: January 2023 to August 2025

AbstractFullPdf
Jan 202318218755
Feb 2023571575223
Mar 2023295298144
Apr 202319920173
May 202319920090
Jun 202315115154
Jul 202313213349
Aug 202316316443
Sep 202315615825
Oct 202311511629
Nov 202315715837
Dec 202317317437
Jan 2024858556
Feb 2024878849
Mar 202410110654
Apr 202410110371
May 2024919654
Jun 2024919246
Jul 2024969743
Aug 2024494721
Sep 20249696288
Oct 2024707053
Nov 2024929347
Dec 20249710139
Jan 202510510543
Feb 202523924252
Mar 2025999969
Apr 202515115261
May 202513313450
Jun 2025788131
Jul 2025110
Aug 2025110
Total435644041986